[go: up one dir, main page]

MA28754B1 - Preparation de compositions pharmaceutiques de medicaments insolubles a l'eau a diffusion rapide et compositions pharmaceutiques ainsi preparees - Google Patents

Preparation de compositions pharmaceutiques de medicaments insolubles a l'eau a diffusion rapide et compositions pharmaceutiques ainsi preparees

Info

Publication number
MA28754B1
MA28754B1 MA29638A MA29638A MA28754B1 MA 28754 B1 MA28754 B1 MA 28754B1 MA 29638 A MA29638 A MA 29638A MA 29638 A MA29638 A MA 29638A MA 28754 B1 MA28754 B1 MA 28754B1
Authority
MA
Morocco
Prior art keywords
pharmaceutical compositions
prepared
preparation
rapid diffusion
insoluble drugs
Prior art date
Application number
MA29638A
Other languages
English (en)
Inventor
Poul Bertelsen
Original Assignee
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps
Publication of MA28754B1 publication Critical patent/MA28754B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA29638A 2004-06-29 2007-01-29 Preparation de compositions pharmaceutiques de medicaments insolubles a l'eau a diffusion rapide et compositions pharmaceutiques ainsi preparees MA28754B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200401021 2004-06-29

Publications (1)

Publication Number Publication Date
MA28754B1 true MA28754B1 (fr) 2007-07-02

Family

ID=34973654

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29638A MA28754B1 (fr) 2004-06-29 2007-01-29 Preparation de compositions pharmaceutiques de medicaments insolubles a l'eau a diffusion rapide et compositions pharmaceutiques ainsi preparees

Country Status (23)

Country Link
US (2) US20070218128A1 (fr)
EP (1) EP1916994B1 (fr)
JP (2) JP5438898B2 (fr)
KR (1) KR100875299B1 (fr)
CN (2) CN1976678B (fr)
AU (1) AU2005256321B2 (fr)
BR (1) BRPI0508063A (fr)
CA (1) CA2572359C (fr)
EA (2) EA200971133A1 (fr)
ES (1) ES2450648T3 (fr)
GE (1) GEP20094671B (fr)
IL (1) IL180071A0 (fr)
MA (1) MA28754B1 (fr)
MX (1) MXPA06015131A (fr)
NO (1) NO20065763L (fr)
NZ (1) NZ552208A (fr)
PL (1) PL1916994T3 (fr)
SA (2) SA108290833B1 (fr)
TN (1) TNSN06434A1 (fr)
TW (1) TWI376242B (fr)
UA (1) UA93353C2 (fr)
WO (1) WO2006000228A2 (fr)
ZA (1) ZA200700531B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1976678B (zh) * 2004-06-29 2010-06-02 奈康明丹麦有限责任公司 水不溶性药快速释放药物组合物的制造方法及通过本方法得到的药物组合物
JP2010536798A (ja) * 2007-08-17 2010-12-02 テバ ファーマシューティカル インダストリーズ リミティド 難溶性薬物の生体利用率を制御するための方法及び組成物
EP2200613B1 (fr) 2007-09-21 2018-09-05 The Johns Hopkins University Dérivés de phénazine et leurs utilisations
BE1018279A3 (fr) * 2008-09-09 2010-08-03 Squarepoint Pointcarre Sprl Composition de nimesulide orodispersible.
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法
US11135188B2 (en) * 2009-05-11 2021-10-05 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents
CN101693030A (zh) * 2009-10-22 2010-04-14 哈尔滨健迪医药技术有限公司 一种用于外用止痛的药物组合物及其制备方法
UA103955C2 (ru) * 2009-11-05 2013-12-10 Алкем Леборетриз Лтд. Стойкая инъекционная фармацевтическая композиция ацеклофенака и способ ее получения
EP2394641A1 (fr) 2010-05-30 2011-12-14 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Formulation pharmaceutique de lornoxicam
US20130122098A1 (en) * 2011-11-14 2013-05-16 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents
CN103565812A (zh) * 2012-08-06 2014-02-12 徐静 一种含氯诺昔康的口服速释止痛制剂的制备方法
WO2015016256A1 (fr) * 2013-07-30 2015-02-05 ライオン株式会社 Comprimé
NO2699580T3 (fr) 2014-01-24 2018-02-24
BE1021194B1 (nl) * 2014-07-07 2015-07-14 Nordic Specialty Pharma Bvba Paracetamol tabletten
EP3260114A1 (fr) 2016-06-21 2017-12-27 Omya International AG Procédé pour la production d'une forme posologique
EP3260115A1 (fr) * 2016-06-21 2017-12-27 Omya International AG Procédé pour la production d'une forme posologique
CN107929247A (zh) * 2016-10-13 2018-04-20 长春海悦药业股份有限公司 一种布洛肾素那敏片剂组合物及其制备方法
AU2019228717C1 (en) 2018-03-01 2025-01-09 Astrazeneca Ab Pharmaceutical compositions comprising (2S)-N-{(1S)-1-cyano-2-[4-(3-methyl-2- oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide
CA3106269A1 (fr) 2018-07-17 2020-01-23 Insmed Incorporated Certains (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides pour le traitement d'une nephropathie lupique
WO2022103620A1 (fr) 2020-11-13 2022-05-19 Bayer Healthcare Llc Comprimés bicouches oraux comprenant de l'acide acétylsalicylique et de la pseudoéphédrine, leurs méthodes de préparation et d'utilisation
JP7565207B2 (ja) * 2020-12-16 2024-10-10 株式会社ファンケル カルノシン酸含有固体組成物及びカルノシン酸の溶出促進方法
CN115645363B (zh) * 2022-10-31 2025-06-10 浙江普利药业有限公司 一种布美他尼注射液及其制备方法
CN115569123B (zh) * 2022-12-08 2023-03-14 则正(济南)生物科技有限公司 一种富马酸伏诺拉生片剂及其制备方法
CN120584108A (zh) 2023-01-06 2025-09-02 英斯梅德股份有限公司 新型可逆dpp1抑制剂及其用途
GR1010732B (el) * 2023-06-02 2024-07-25 Ιουλια Κλεωνος Τσετη Φαρμακευτικη συνθεση ιβουπροφαινης και παρακεταμολης για απο του στοματος χορηγηση
CN118373833A (zh) * 2024-03-21 2024-07-23 浙江震元制药有限公司 一种氯诺昔康-扑热息痛共无定形钠盐及其制备方法和应用、消炎镇痛药物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
JP2906528B2 (ja) * 1990-02-14 1999-06-21 大正製薬株式会社 吸収を促進した内服用固形製剤
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
MX9600857A (es) * 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US6974595B1 (en) * 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
EP1007049A1 (fr) * 1997-08-27 2000-06-14 Hexal AG Nouvelles compositions pharmaceutiques de meloxicam presentant une solubilite et une biodisponibilite ameliorees
CN1277550A (zh) * 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
DK1109534T3 (da) * 1998-09-10 2003-06-10 Nycomed Danmark As Farmaceutiske præparater med quick release af den aktive substans
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
OA11831A (en) * 1999-12-08 2005-08-23 Pharmacia Corp Polymorphic crystalline forms of celecoxib.
US20030124176A1 (en) * 1999-12-16 2003-07-03 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6656492B2 (en) * 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
CA2461042A1 (fr) * 2001-09-25 2003-04-03 Ashish Madan Procede de preparation d'une forme posologique a dissolution rapide
WO2004000284A1 (fr) * 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques a dissolution amelioree
RS20050390A (sr) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Farmaceutska kompozicija koja obuhvata ltb4 antagonist i koks-2 inhibitor ili kombinovani koks1/2 inhibitor
WO2004071490A1 (fr) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Systeme de solvants de medicament a peine soluble a taux d'elution ameliore
US20040220264A1 (en) * 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
CN1976678B (zh) * 2004-06-29 2010-06-02 奈康明丹麦有限责任公司 水不溶性药快速释放药物组合物的制造方法及通过本方法得到的药物组合物

Also Published As

Publication number Publication date
CN101513391A (zh) 2009-08-26
SA05260191B1 (ar) 2009-09-02
CN101513391B (zh) 2013-03-13
WO2006000228A2 (fr) 2006-01-05
GEP20094671B (en) 2009-04-27
EA200971133A1 (ru) 2010-10-29
TWI376242B (en) 2012-11-11
EA200700078A1 (ru) 2007-06-29
NO20065763L (no) 2007-01-29
CN1976678A (zh) 2007-06-06
US20070218128A1 (en) 2007-09-20
KR20070032035A (ko) 2007-03-20
EA014443B1 (ru) 2010-12-30
KR100875299B1 (ko) 2008-12-23
WO2006000228A3 (fr) 2006-08-31
ZA200700531B (en) 2009-09-30
PL1916994T3 (pl) 2014-05-30
CA2572359C (fr) 2010-08-03
CN1976678B (zh) 2010-06-02
US20130059842A1 (en) 2013-03-07
SA108290833B1 (ar) 2012-03-24
JP2011213730A (ja) 2011-10-27
ES2450648T3 (es) 2014-03-25
MXPA06015131A (es) 2007-03-26
JP2008504307A (ja) 2008-02-14
CA2572359A1 (fr) 2006-01-05
IL180071A0 (en) 2007-05-15
TW200605919A (en) 2006-02-16
EP1916994A2 (fr) 2008-05-07
JP5438898B2 (ja) 2014-03-12
TNSN06434A1 (en) 2008-02-22
AU2005256321A1 (en) 2006-01-05
BRPI0508063A (pt) 2007-07-17
EP1916994B1 (fr) 2013-12-11
UA93353C2 (ru) 2011-02-10
WO2006000228B1 (fr) 2006-11-09
AU2005256321B2 (en) 2008-11-20
NZ552208A (en) 2008-11-28

Similar Documents

Publication Publication Date Title
MA28754B1 (fr) Preparation de compositions pharmaceutiques de medicaments insolubles a l'eau a diffusion rapide et compositions pharmaceutiques ainsi preparees
EP1799285A4 (fr) Dispositifs a seringues et methodes de melange et d'administration de medicaments
EP1513825A4 (fr) Medicament anti-tuberculeux: compositions et methodes
HUE040046T2 (hu) Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
EP2161021A4 (fr) Préparation de film médicinal avec une propriété de dissolution rapide et une flexibilité
EP1696961A4 (fr) Compositions a nanoparticules de medicaments solubles dans l'eau administrees par voie orale et methodes de preparation
EP1366760A4 (fr) Comprimes a dissolution rapide dans la cavite buccale
EP1804717A4 (fr) Revetement d'administration de medicament pouvant etre utilise avec une endoprothese vasculaire
EP1796629A4 (fr) Vehicule d'administration semi-solide et compositions pharmaceutiques
WO2005046640A3 (fr) Plateforme d'administration de medicaments a sites multiples
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
IL236426B (en) Use of a compound in combination with bortezomib to prepare a drug for a neoplastic disease and a pharmaceutical preparation containing a compound and bortezomib
EP1765379A4 (fr) Compositions pharmaceutiques de co-cristal et methodes d'utilisation associees
IS8642A (is) Aðferð og sett til þess að gefa lyf með eimgjöf
EE200200634A (et) Atsüülfenüülkarbamiidi derivaadid, nende saamine ja kasutamine veresuhkrut alandava ravimi valmistamiseks ning neid sisaldav ravim
EP1968684A4 (fr) Soulagement de la congestion et de l'obstruction nasales et administration de medicament
WO2007123865A3 (fr) Traitement de maladies inflammatoires et ulcéreuses du côlon à l'aide d'antagonistes opioïdes
DK1957110T3 (da) Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed
TR200000369T2 (tr) Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi.
ATE426635T1 (de) Arzneimittelverabreichung
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
EP2497466A3 (fr) Préparation pour administration orale
WO2006050155A3 (fr) Compositions therapeutiques contre le cancer
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
DE60322454D1 (de) Pharmazeutische Zusammensetzungen zur oralen und topischen Verabreichung